Works matching IS 2160763X AND DT 2020 AND VI 9 AND IP 5
Results: 12
Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 552, doi. 10.1002/cpdd.840
- By:
- Publication type:
- Article
Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design).
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 610, doi. 10.1002/cpdd.813
- By:
- Publication type:
- Article
Pharmacokinetics of Gepotidacin in Renal Impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 560, doi. 10.1002/cpdd.807
- By:
- Publication type:
- Article
Bioequivalence and Bioavailability of an Orodispersible Tablet of Sildenafil Citrate in Healthy Chinese Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 573, doi. 10.1002/cpdd.806
- By:
- Publication type:
- Article
Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With BRAF<sup>V600</sup> Mutation–Positive Malignancies.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 651, doi. 10.1002/cpdd.788
- By:
- Publication type:
- Article
Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 629, doi. 10.1002/cpdd.768
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence of 2 Olanzapine Orally Disintegrating Tablet Products in Healthy Chinese Subjects Under Fed and Fasting Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 593, doi. 10.1002/cpdd.765
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Safety of a Single Escalating Dose and Repeated Doses of Rasagiline Transdermal Patch in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 602, doi. 10.1002/cpdd.761
- By:
- Publication type:
- Article
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 639, doi. 10.1002/cpdd.750
- By:
- Publication type:
- Article
Open‐Label, Randomized, Single‐Dose, 2‐Period, 2‐Sequence Crossover, Comparative Pharmacokinetic Study to Evaluate Bioequivalence of 2 Oral Formulations of Olanzapine Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 621, doi. 10.1002/cpdd.743
- By:
- Publication type:
- Article
Comparison of In Vitro and In Vivo Percutaneous Absorption Across Human Skin Using BAY1003803 Formulated as Ointment and Cream.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 582, doi. 10.1002/cpdd.736
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 547, doi. 10.1002/cpdd.679
- Publication type:
- Article